LivaNova (LIVN) Revenue (2014 - 2026)
LivaNova (LIVN) reported Revenue of $362.3 million for Q1 2026, up 14.33% on a YoY basis from $316.9 million in Q1 2025, and little changed sequentially from $360.9 million in Q4 2025.
LivaNova (LIVN) Revenue (2014 - 2026) Analysis & Trends
LivaNova (LIVN) has 13 years of Revenue data on file, last reported at $362.3 million in Q1 2026.
- For the quarter ending Q1 2026, Revenue rose 14.33% year-over-year to $362.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 billion (up 12.39% YoY), and the FY2025 full-year result was $1.4 billion, up 10.74% from the prior year.
- Revenue held at $362.3 million in Q1 2026, from $360.9 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $362.3 million in Q1 2026 to a low of $240.2 million in Q1 2022.
- A 5-year average of $304.7 million and a median of $310.1 million in 2023 frame the typical range for Revenue.
- Across the five-year window, Revenue retreated 3.91% in 2022 and increased 15.63% in 2023, its largest moves.
- Tracing LIVN's Revenue over 5 years: stood at $274.9 million in 2022, then advanced by 12.83% to $310.1 million in 2023, then gained by 3.77% to $321.8 million in 2024, then rose by 12.15% to $360.9 million in 2025, then increased by 0.37% to $362.3 million in 2026.
- Business Quant data shows LIVN's Revenue at $362.3 million in Q1 2026, $360.9 million in Q4 2025, and $357.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 11.16 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.02 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 9.81 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 5.20 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.65 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.19 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.57 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn | 362.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 362.26 Mn |
| Dec 31, 2025 | 360.92 Mn |
| Sep 30, 2025 | 357.75 Mn |
| Jun 30, 2025 | 352.52 Mn |
| Mar 31, 2025 | 316.86 Mn |
| Dec 31, 2024 | 321.83 Mn |
| Sep 30, 2024 | 318.12 Mn |
| Jun 30, 2024 | 318.58 Mn |
| Mar 31, 2024 | 294.91 Mn |
| Dec 31, 2023 | 310.13 Mn |
| Sep 30, 2023 | 286.11 Mn |
| Jun 30, 2023 | 293.88 Mn |
| Mar 31, 2023 | 263.42 Mn |
| Dec 31, 2022 | 274.87 Mn |
| Sep 30, 2022 | 252.61 Mn |
| Jun 30, 2022 | 254.15 Mn |
| Mar 31, 2022 | 240.18 Mn |
| Dec 31, 2021 | 270.06 Mn |
| Sep 30, 2021 | 253.22 Mn |
| Jun 30, 2021 | 264.48 Mn |